Zheng Yuan-Liang, Wu Dan-Ni, Huang Ri-Sheng
Department of Thoracic Surgery, The Dingli Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, 325000, China.
Heliyon. 2024 May 4;10(9):e30753. doi: 10.1016/j.heliyon.2024.e30753. eCollection 2024 May 15.
The increasing identification of pulmonary nodules has led to a growing emphasis on segmentectomy. Nevertheless, the surgical process for segmentectomy is complex and optimizing segmentectomy is a critical clinical concern. This study aimed to evaluate the safety and short- and long-term efficacy of V6-preserving superior segmentectomy.
We performed a retrospective analysis of patients who underwent thoracoscopic superior segmentectomy at our hospital between January 2019 and June 2020. Eligible patients were categorized into an V6 vein-preserving segmentectomy (VVPS) group and a Non V6 vein-preserving segmentectomy (NVVPS) group depending on the preservation of V6. Primary outcome measures encompassed the evaluation of surgical safety (surgical margins, 3-year overall survival, and disease-free survival), whereas secondary measures included postoperative complication rates, operative time, estimated intraoperative blood loss, length of hospital stay, and associated costs.
The analysis included a final cohort of 78 patients. In the NVVPS group (n = 43), 95.3 % of patients exceeded the tumor diameter, and no positive surgical margins were observed. The 3-year overall survival (OS) and disease-free survival (DFS) rates for the NVVPS group were 95.3 %, with no significant differences in OS (p = 0.572) and DFS (P = 0.800) compared with the VVPS group. Additionally, the median total hospitalization cost for the NVVPS group was 41,400 RMB (IQR, 38,800-43,400), which was significantly lower than that of the VVPS group, showing statistical significance (P < 0.05). No statistically significant differences were observed in the incidence of postoperative complications and length of stay between the two groups (P > 0.05).
V6-preserving superior segmentectomy is a secure and optimized surgical alternative. Its streamlined procedure facilitates easier adoption in primary healthcare facilities, rendering it a superior choice for superior segmentectomy.
肺结节的检出率不断提高,使得肺段切除术越来越受到重视。然而,肺段切除术的手术过程复杂,优化肺段切除术是一个关键的临床问题。本研究旨在评估保留V6的上叶肺段切除术的安全性及短期和长期疗效。
我们对2019年1月至2020年6月在我院接受胸腔镜上叶肺段切除术的患者进行了回顾性分析。根据是否保留V6,将符合条件的患者分为保留V6静脉的肺段切除术(VVPS)组和不保留V6静脉的肺段切除术(NVVPS)组。主要结局指标包括评估手术安全性(手术切缘、3年总生存率和无病生存率),次要指标包括术后并发症发生率、手术时间、估计术中出血量、住院时间及相关费用。
分析纳入了78例患者的最终队列。在NVVPS组(n = 43)中,95.3%的患者肿瘤直径超标,未观察到手术切缘阳性。NVVPS组的3年总生存率(OS)和无病生存率(DFS)均为95.3%,与VVPS组相比,OS(p = 0.572)和DFS(P = 0.800)无显著差异。此外,NVVPS组的中位总住院费用为41,400元(IQR,38,800 - 43,400),显著低于VVPS组,差异有统计学意义(P < 0.05)。两组术后并发症发生率和住院时间无统计学差异(P > 0.05)。
保留V6的上叶肺段切除术是一种安全且优化的手术选择。其简化的手术过程便于在基层医疗机构中更易采用,使其成为上叶肺段切除术的更佳选择。